5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with lidocaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clauss, W; Fischer, H; Hegel, U; Illek, B; Kreusel, KM | 1 |
| Fischer, H; Illek, B; Machen, TE | 1 |
2 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and lidocaine
| Article | Year |
|---|---|
Volume-sensitive basolateral K+ channels in HT-29/B6 cells: block by lidocaine, quinidine, NPPB, and Ba2+.
Topics: Adenocarcinoma; Animals; Barium; Cell Membrane Permeability; Chlorides; Colonic Neoplasms; Electrophysiology; Humans; Lidocaine; Nitrobenzoates; Potassium; Potassium Channels; Quinidine; Rubidium; Tumor Cells, Cultured | 1992 |
Intracellular Ca2+ signalling is modulated by K+ channel blockers in colonic epithelial cells (HT-29/B6).
Topics: Atropine; Calcium; Carbachol; Colonic Neoplasms; Epithelial Cells; Epithelium; Humans; Intracellular Membranes; Lanthanum; Lidocaine; Nitrobenzoates; Potassium Channels; Signal Transduction; Tumor Cells, Cultured | 1992 |